Wave Life Sciences is trading 5.25% up now at $5.31, rebounding amid a broader risk-on session following an in-line July CPI report.
- Shares fell 16.89% to $5.04 on August 11; the Nasdaq Composite is up 0.58%.
- Managementβs August 11 Bank of America SMID Cap conference discussion and scheduled August 12 Canaccord presentation provide fresh investor focus on WVE-007, WVE-006, and WVE-008.
- No clearly reported new company-specific announcement explains the move.